Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Virta Health Announces First-of-its-Kind Peer-Reviewed Study Proving Its Approach Is an Effective Off-Ramp From GLP-1s for Sustained Weight Loss Company builds on nearly 10 years of GLP-1 experience, expanding its Sustainable Weight Loss solution to deliver medication-free and medication-assisted weight loss Virta Health has released first-of-its-kind, peer-reviewed data demonstrating the companys approach to personalized nutrition therapy results in sustained weight loss after the discontinuation of glucagon-like peptide-1 receptor agonists (GLP-1s), including Ozempic
The results were notable: Dendritic length increased Branching complexity rose Total junction counts went up, indicating enhanced synaptic connectivity and plasticity Figure 3
The overexpression of TDP-43 in astrocytes causes neurodegeneration via a PTP1B-mediated inflammatory response
J.CoarfaC.ZarrabiA
L.ZhengH.CoreyK
:
.png.jpg)
US$ 29.46
US$ 28.62
US$ 22.87
